CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

The country's premier medical institution said that its studies have found no connection between Covid jabs and sudden deaths ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

As the UK market grapples with the repercussions of faltering trade data from China, the FTSE 100 and FTSE 250 indices have experienced declines, reflecting broader global economic concerns. In such a ...

AstraZeneca CEO discusses leaving London for US and Japan facing new, bigger tariff - Stock markets updates and business news ...

The yields on UK ten year bonds rose sharply on Wednesday as Keir Starmer failed to guarantee the job of chancellor Rachel ...

Housebuilding sector bounced back from some weakness, with Cairn Homes and Glenveagh Properties were each up 2% ...

Top riser on the FTSE 350 today is B&M European Value Retail SA (LSE:BME) after analysts at RBC Capital Markets joined those ...

Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered ...

When Lea Hughes first spotted a small lump on her breast she was reassured it was just due to 'hormones'. But two years later ...